Cell-based approaches to the engineering of vascularized bone tissue

Cytotherapy

Volumn 15, Issue 11, 2013, Pages 1309-1322

  Rao, Rameshwar R ^a   Stegemann, Jan P ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Bone; Cell therapy; Orthopedics; Stem cells; Tissue engineering; Vascularization

Indexed keywords

GROWTH FACTOR;

ANGIOGENESIS; BONE DEFECT; BONE DEVELOPMENT; BONE TISSUE; CELL FUNCTION; CELL THERAPY; CELL TYPE; COCULTURE; FRACTURE; FRACTURE NONUNION; GENE TARGETING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION; VASCULARIZATION; VASCULARIZED BONE TISSUE;

ANIMALIA;

BONE; CELL THERAPY; ORTHOPEDICS; STEM CELLS; TISSUE ENGINEERING; VASCULARIZATION;

BONE AND BONES; BONE REGENERATION; BONE TRANSPLANTATION; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; OSTEOGENESIS; TISSUE ENGINEERING;

EID: 84884981488     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.06.005     Document Type: Review

References (126)

1. HCUP Healthcare Cost and Utilization Project 2006, Agency for Healthcare Research and Quality, Rockville, MD.
2. Soucacos P.N., Dailiana Z., Beris A.E., Johnson E.O. Vascularised bone grafts for the management of non-union. Injury 2006, 37:S41-S50.
3. Khan Y., Yaszemski M.J., Mikos A.G., Laurencin C.T. Tissue engineering of bone: material and matrix considerations. JBone Joint Surg Am 2008, 90:36-42.
4. Wheeler D.L., Enneking W.F. Allograft bone decreases in strength in vivo over time. Clin Orthop Relat Res 2005, 435:36-42.
5. Schroeder J.E., Mosheiff R. Tissue engineering approaches for bone repair: concepts and evidence. Injury 2011, 42:609-613.
6. Sayyidmousavi A., Bougherara H. Investigation of stress shielding around the Stryker Omnifit and Exeter periprosthetic hip implants using an irreversible thermodynamic-based model. JBiomed Mater Res B Appl Biomater 2012, 100:1416-1424.
7. Barr T., McNamara A.J., Sándor G.K., Clokie C.M., Peel S.A. Comparison of the osteoinductivity of bioimplants containing recombinant human bone morphogenetic proteins 2 (Infuse) and 7 (OP-1). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 109:531-540.
8. McKay W.F., Peckham S.M., Badura J.M. Acomprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop 2007, 31:729-734.
9. Carreon L.Y., Glassman S.D., Brock D.C., Dimar J.R., Puno R.M., Campbell M.J. Adverse events in patients re-exposed to bone morphogenetic protein for spine surgery. Spine 2008, 33:391-393.
10. Shahlaie K., Kim K.D. Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma. Spine 2008, 33:2361-2366.
11. Epstein N.E. Pros, cons, and costs of INFUSE in spinal surgery. Surg Neurol Int 2011, 2:10.
12. Carragee E.J., Hurwitz E.L., Weiner B.K. Acritical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 2011, 11:471-491.
13. Carragee E.J., Baker R.M., Benzel E.C., Bigos S.J., Cheng I., Corbin T.P., et al. Abiologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research. Spine J 2012, 12:877-880.
14. Even J., Eskander M., Kang J. Bone morphogenetic protein in spine surgery: current and future uses. JAm Acad Orthop Surg 2012, 20:547-552.
15. Clarke B. Normal bone anatomy and physiology. Clin J Am Soc Nephrol 2008, 3(Suppl 3):S131-S139.
16. Sommerfeldt D.W., Rubin C.T. Biology of bone and how it orchestrates the form and function of the skeleton. Eur Spine J 2001, 10:S86-S95.
17. Ross M.H., Pawlina W. Histology: A Text and Atlas 2010, 218-253. Lippincott Williams & Wilkins, Philadelphia.
18. Klein-Nulend J., Bacabac R.G., Mullender M.G. Mechanobiology of bone tissue. Pathol Biol 2005, 53:576-580.
19. Allori A.C., Sailon A.M., Pan J.H., Warren S.M. Biological basis of bone formation, remodeling, and repair, part III: biomechanical forces. Tissue Eng Part B Rev 2008, 14:285-293.
20. Chen J.H., Liu C., You L., Simmons C.A. Boning up on Wolff's Law: mechanical regulation of the cells that make and maintain bone. JBiomech 2010, 43:108-118.
21. Bodle J.C., Hanson A.D., Loboa E.G. Adipose-derived stem cells in functional bone tissue engineering: lessons from bone mechanobiology. Tissue Eng Part B Rev 2011, 17:195-211.
22. Khurana J.S., Safadi F.F. Development and Bone Biology. Essentials in Bone and Soft-Tissue Pathology 2010, 1-15. Springer Science+Business Media, LLC, New York.
23. Buck D.W., Dumanian G.A. Bone biology and physiology, part I: the fundamentals. Plast Reconstr Surg 2012, 129:1314-1320.
24. Fang T.D., Salim A., Xia W., Nacamuli R.P., Guccione S., Song H.M., et al. Angiogenesis is required for successful bone induction during distraction osteogenesis. JBone Miner Res 2005, 20:1114-1124.
25. Augello A., Kurth T.B., De Bari C. Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater 2010, 20:121-133.
26. Rosenbaum A.J., Grande D.A., Dines J.S. The use of mesenchymal stem cells in tissue engineering: a global assessment. Organogenesis 2008, 4:23-27.
27. Bieback K., Wuchter P., Besser D., Franke W., Becker M., Ott M., START-MSC Consortium, et al. Mesenchymal stromalcells (MSCs): science and f(r)iction. JMol Med 2012, 90:773-782.
28. Motaln H., Schichor C., Lah T.T. Human mesenchymal stem cells and their use in cell-based therapies. Cancer 2010, 116:2519-2530.
29. van Gastel N., Torrekens S., Roberts S.J., Moermans K., Schrooten J., Carmeliet P., et al. Engineering vascularized bone: osteogenic and proangiogenic potential of murine periosteal cells. Stem Cells 2012, 30:2460-2471.
30. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
31. Vater C., Kasten P., Stiehler M. Culture media for the differentiation of mesenchymal stromal cells. Acta Biomater 2011, 7:463-477.
32. Davis H.E., Rao R.R., He J., Leach J.K. Biomimetic scaffolds fabricated from apatite-coated polymer microspheres. JBiomed Mater Res A 2009, 90:1021-1031.
33. Wang L., Stegemann J.P. Thermogelling chitosan and collagen composite hydrogels initiated with beta-glycerophosphate for bone tissue engineering. Biomaterials 2010, 31:3976-3985.
34. Wang L., Stegemann J.P. Glyoxal crosslinking of cell-seeded chitosan/collagen hydrogels for bone regeneration. Acta Biomater 2011, 7:2410-2417.
35. Ogata Y., Yamauchi M., Kim R.H., Li J.J., Freedman L.P., Sodek J. Glucocorticoid regulation of bone sialoprotein (BSP) gene expression: identification of a glucocorticoid response element in the bone sialoprotein gene promoter. Eur J Biochem 1995, 230:183-192.
36. Hamidouche Z., Fromigué O., Ringe J., Häupl T., Vaudin P., Pagès J.C., et al. Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc Natl Acad Sci U S A 2009, 106:18587-18591.
37. Takamizawa S., Maehata Y., Imai K., Senoo H., Sato S., Hata R. Effects of ascorbic acid and ascorbic acid 2-phosphate, a long-acting vitamin C derivative, on the proliferation and differentiation of human osteoblast-like cells. Cell Biol Int 2004, 28:255-265.
38. Chung C.H., Golub E.E., Forbes E., Tokuoka T., Shapiro I.M. Mechanism of action of beta-glycerophosphate on bone cell mineralization. Calcif Tissue Int 1992, 51:305-311.
39. Li D., Zhou J., Chowdhury F., Cheng J., Wang N., Wang F. Role of mechanical factors in fate decisions of stem cells. Regen Med 2011, 6:229-240.
40. Rehfeldt F., Engler A.J., Eckhardt A., Ahmed F., Discher D.E. Cell responses to the mechanochemical microenvironment: implications for regenerative medicine and drug delivery. Adv Drug Deliv Rev 2007, 59:1329-1339.
41. Carpentier B., Layrolle P., Legallais C. Bioreactors for bone tissue engineering. Int J Artif Organs 2011, 34:259-270.
42. Mauney J.R., Volloch V., Kaplan D.L. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 2005, 11:787-802.
43. Hidalgo-Bastida L.A., Cartmell S.H. Mesenchymal stem cells, osteoblasts and extracellular matrix proteins: enhancing cell adhesion and differentiation for bone tissue engineering. Tissue Eng Part B Rev 2010, 16:405-412.
44. Salem H.K., Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010, 28:585-596.
45. Yi T., Song S.U. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Arch Pharm Res 2012, 35:213-221.
46. Abumaree M., Al Jumah M., Pace R.A., Kalionis B. Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev 2012, 8:375-392.
47. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
48. Shi M., Liu Z.W., Wang F.S. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 2011, 164:1-8.
49. Yagi H., Soto-Gutierrez A., Parekkadan B., Kitagawa Y., Tompkins R.G., Kobayashi N., et al. Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant 2010, 19:667-679.
50. Gir P., Oni G., Brown S.A., Mojallal A., Rohrich R.J. Human adipose stem cells: current clinical applications. Plast Reconstr Surg 2012, 129:1277-1290.
51. Lee K., Chan C.K., Patil N., Goodman S.B. Cell therapy for bone regeneration: bench to bedside. JBiomed Mater Res B Appl Biomater 2009, 89:252-263.
52. Zeve D., Tang W., Graff J. Fighting fat with fat: the expanding field of adipose stem cells. Cell Stem Cell 2009, 5:472-481.
53. Correia C., Bhumiratana S., Yan L.P., Oliveira A.L., Gimble J.M., Rockwood D., et al. Development of silk-based scaffolds for tissue engineering of bone from human adipose-derived stem cells. Acta Biomater 2012, 8:2483-2492.
54. Brayfield C.A., Marra K.G., Rubin J.P. Adipose tissue regeneration. Curr Stem Cell Res Ther 2010, 5:116-121.
55. Wang W., Cao B., Cui L., Cai J., Yin J. Adipose tissue engineering with human adipose tissue-derived adult stem cells and a novel porous scaffold. JBiomed Mater Res B Appl Biomater 2013, 101:68-75.
56. Hildner F., Albrecht C., Gabriel C., Redl H., van Griensven M. State of the art and future perspectives of articular cartilage regeneration: a focus on adipose-derived stem cells and platelet-derived products. JTissue Eng Regen Med 2011, 5:e36-e51.
57. Cheng N.C., Estes B.T., Young T.H., Guilak F. Genipin-crosslinked cartilage-derived matrix as a scaffold for human adipose-derived stem cell chondrogenesis. Tissue Eng Part A 2013, 19:484-496.
58. Estes B.T., Diekman B.O., Gimble J.M., Guilak F. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 2010, 5:1294-1311.
59. Cui L., Yin S., Liu W., Li N., Zhang W., Cao Y. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng 2007, 13:1185-1195.
60. De Miguel M.P., Fuentes-Julián S., Blázquez-Martínez A., Pascual C.Y., Aller M.A., Arias J., Arnalich-Montiel F. Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med 2012, 12:574-591.
61. Burdick J.A., Anseth K.S. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials 2002, 23:4315-4323.
62. Benoit D.S., Durney A.R., Anseth K.S. Manipulations in hydrogel degradation behavior enhance osteoblast function and mineralized tissue formation. Tissue Eng 2006, 12:1663-1673.
63. Rodrigues S.C., Salgado C.L., Sahu A., Garcia M.P., Fernandes M.H., Monteiro F.J. Preparation and characterization of collagen-nanohydroxyapatite biocomposite scaffolds by cryogelation method for bone tissue engineering applications. J Biomed Mater Res A 2013, 101:1080-1094.
64. Müller U., Imwinkelried T., Horst M., Sievers M., Graf-Hausner U. Do human osteoblasts grow into open-porous titanium?. Eur Cell Mater 2006, 11:8-15.
65. Ignatius A., Blessing H., Liedert A., Schmidt C., Neidlinger-Wilke C., Kaspar D., et al. Tissue engineering of bone: effects of mechanical strain on osteoblastic cells in type I collagen matrices. Biomaterials 2005, 26:311-318.
66. Khatiwala C.B., Kim P.D., Peyton S.R., Putnam A.J. ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK. JBone Miner Res 2009, 24:886-898.
67. Gibon E., Batke B., Jawad M.U., Fritton K., Rao A., Yao Z., et al. MC3T3-E1 osteoprogenitor cells systemically migrate to a bone defect and enhance bone healing. Tissue Eng Part A 2012, 9-10:968-973.
68. Jayakumar P., Di Silvio L. Osteoblasts in bone tissue engineering. Proc Inst Mech Eng H 2010, 224:1415-1440.
69. Khan O.F., Sefton M.V. Endothelialized biomaterials for tissue engineering applications in vivo. Trends Biotechnol 2011, 29:379-387.
70. Hendrickx B., Vranckx J.J., Luttun A. Cell-based vascularization strategies for skin tissue engineering. Tissue Eng Part B Rev 2011, 17:13-24.
71. Lokmic Z., Mitchell G.M. Engineering the microcirculation. Tissue Eng Part B Rev 2008, 14:87-103.
72. Rao R.R., Peterson A.W., Ceccarelli J., Putnam A.J., Stegemann J.P. Matrix composition regulates three-dimensional network formationby endothelial cells and mesenchymal stem cells incollagen/fibrin materials. Angiogenesis 2012, 15:253-264.
73. Zhang G., Suggs L.J. Matrices and scaffolds for drug delivery in vascular tissue engineering. Adv Drug Deliv Rev 2007, 59:360-373.
74. Nomi M., Atala A., Coppi P.D., Soker S. Principals of neovascularization for tissue engineering. Mol Aspects Med 2002, 23:463-483.
75. Kniazeva E., Putnam A.J. Endothelial cell traction and ECM density influence both capillary morphogenesis and maintenance in 3-D. Am J Physiol Cell Physiol 2009, 297:C179-C187.
76. Kachgal S., Carrion B., Janson I.A., Putnam A.J. Bone marrow stromal cells stimulate an angiogenic program that requires endothelial MT1-MMP. JCell Physiol 2012, 227:3546-3555.
77. Grainger S.J., Putnam A.J. Assessing the permeability of engineered capillary networks in a 3D culture. PLoS One 2011, 6:e22086.
78. Davison P.M., Bensch K., Karasek M.A. Isolation and growth of endothelial cells from the microvessels of the newborn human foreskin in cell culture. JInvest Dermatol 1980, 75:316-321.
79. Richard L., Velasco P., Detmar M. Asimple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells. Exp Cell Res 1998, 240:1-6.
80. Eckermann C.W., Lehle K., Schmid S.A., Wheatley D.N., Kunz-Schughart L.A. Characterization and modulation of fibroblast/endothelial cell co-cultures for the in vitro preformation of three-dimensional tubular networks. Cell Biol Int 2011, 35:1097-1110.
81. Nör J.E., Peters M.C., Christensen J.B., Sutorik M.M., Linn S., Khan M.K., et al. Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest 2001, 81:453-463.
82. Melero-Martin J.M., Khan Z.A., Picard A., Wu X., Paruchuri S., Bischoff J. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 2007, 109:4761-4768.
83. Young P.P., Vaughan D.E., Hatzopoulos A.K. Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis 2007, 49:421-429.
84. Au P., Daheron L.M., Duda D.G., Cohen K.S., Tyrrell J.A., Lanning R.M., et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 2008, 111:1302-1305.
85. Choong C.S., Hutmacher D.W., Triffitt J.T. Co-culture of bone marrow fibroblasts and endothelial cells on modified polycaprolactone substrates for enhanced potentials in bone tissue engineering. Tissue Eng 2006, 12:2521-2531.
86. Correia C, Grayson W, Eton R, Gimble JM, Sousa RA, Reis RL, etal. Human adipose-derived cells can serve as a single-cell source for the in vitro cultivation of vascularized bone grafts [published online ahead of print August 17, 2012]. JTissue Eng Regen Med.
87. Zhang R., Gao Z., Geng W., Yan X., Chen F., Liu Y. Engineering vascularized bone graft with osteogenic and angiogenic lineage differentiated bone marrow mesenchymal stem cells. Artif Organs 2012, 36:1036-1046.
88. Villars F., Guillotin B., Amédée T., Dutoya S., Bordenave L., Bareille R., et al. Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol 2002, 282:C775-C785.
89. Laranjeira M.S., Fernandes M.H., Monteiro F.J. Reciprocal induction of human dermal microvascular endothelial cells and human mesenchymal stem cells: time-dependent profile in a co-culture system. Cell Prolif 2012, 45:320-334.
90. Wang J., Ye Y., Tian H., Yang S., Jin X., Tong W., et al. In vitro osteogenesis of human adipose-derived stem cells by coculture with human umbilical vein endothelial cells. Biochem Biophys Res Commun 2011, 412:143-149.
91. Stahl A., Wenger A., Weber H., Stark G.B., Augustin H.G., Finkenzeller G. Bi-directional cell contact-dependent regulation of gene expression between endothelial cells and osteoblasts in a three-dimensional spheroidal coculture model. Biochem Biophys Res Commun 2004, 322:684-692.
92. Hager S., Lampert F.M., Orimo H., Stark G.B., Finkenzeller G. Up-regulation of alkaline phosphatase expression in human primary osteoblasts by cocultivation with primary endothelial cells is mediated by p38 mitogen-activated protein kinase-dependent mRNA stabilization. Tissue Eng Part A 2009, 15:3437-3447.
93. Xue Y., Xing Z., Hellem S., Arvidson K., Mustafa K. Endothelial cells influence the osteogenic potential of bone marrow stromal cells. Biomed Eng Online 2009, 8:34.
94. Guillotin B., Bareille R., Bourget C., Bordenave L., Amédée J. Interaction between human umbilical vein endothelial cells and human osteoprogenitors triggers pleiotropic effect that may support osteoblastic function. Bone 2008, 42:1080-1091.
95. Leszczynska J., Zyzynska-Granica B., Koziak K., Ruminski S., Lewandowska-Szumiel M. Contribution of endothelial cells to human bone-derived cells expansion in coculture. Tissue Eng Part A 2013, 19:393-402.
96. Steiner D., Lampert F., Stark G.B., Finkenzeller G. Effects of endothelial cells on proliferation and survival of human mesenchymal stem cells and primary osteoblasts. JOrthop Res 2012, 30:1682-1689.
97. Kaigler D., Krebsbach P.H., Polverini P.J., Mooney D.J. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng 2003, 9:95-103.
98. Grellier M., Ferreira-Tojais N., Bourget C., Bareille R., Guillemot F., Amédée J. Role of vascular endothelial growth factor in the communication between human osteoprogenitors and endothelial cells. JCell Biochem 2009, 106:390-398.
99. Dohle E., Fuchs S., Kolbe M., Hofmann A., Schmidt H., Kirkpatrick C.J. Sonic hedgehog promotes angiogenesis and osteogenesis in a coculture system consisting of primary osteoblasts and outgrowth endothelial cells. Tissue Eng Part A 2010, 16:1235-1237.
100. Hoch A.I., Binder B.Y., Genetos D.C., Leach J.K. Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells. PLoS One 2012, 7:e35579.
101. Bidarra S.J., Barrias C.C., Barbosa M.A., Soares R., Amédée J., Granja P.L. Phenotypic and proliferative modulation of human mesenchymal stem cells via crosstalk with endothelial cells. Stem Cell Res 2011, 7:186-197.
102. Ma J., van den Beucken J.J., Yang F., Both S.K., Cui F.Z., Pan J., et al. Coculture of osteoblasts and endothelial cells: optimization of culture medium and cell ratio. Tissue Eng Part C Methods 2011, 17:349-357.
103. Kolbe M., Xiang Z., Dohle E., Tonak M., Kirkpatrick C.J., Fuchs S. Paracrine effects influenced by cell culture medium and consequences on microvessel-like structures in cocultures of mesenchymal stem cells and outgrowth endothelial cells. Tissue Eng Part A 2011, 17:2199-2212.
104. Pedersen T.O., Blois A.L., Xue Y., Xing Z., Cottler-Fox M., Fristad I., et al. Osteogenic stimulatory conditions enhance growth and maturation of endothelial cell microvascular networks in culture with mesenchymal stem cells. JTissue Eng 2012, 3. 2041731412443236.
105. Thébaud N.B., Siadous R., Bareille R., Remy M., Daculsi R., Amédée J., et al. Whatever their differentiation status, human progenitor derived-or mature-endothelial cells induce osteoblastic differentiation of bone marrow stromal cells. JTissue Eng Regen Med 2012, 6:e51-e60.
106. Saleh F.A., Whyte M., Genever P.G. Effects of endothelial cellson human mesenchymal stem cell activity in a three-dimensional in vitro model. Eur Cell Mater 2011, 22:242-257.
107. Santos M.I., Unger R.E., Sousa R.A., Reis R.L., Kirkpatrick C.J. Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone-starch scaffold and the invitro development of vascularization. Biomaterials 2009, 30:4407-4415.
108. Kang Y., Kim S., Fahrenholtz M., Khademhosseini A., Yang Y. Osteogenic and angiogenic potentials of monocultured and co-cultured human-bone-marrow-derived mesenchymal stem cells and human-umbilical-vein endothelial cells on three-dimensional porous beta-tricalcium phosphate scaffold. Acta Biomater 2013, 9:4906-4915.
109. Nukavarapu S.P., Amini A.R. Optimal scaffold design and effective progenitor cell identification for the regeneration of vascularized bone. Conf Proc IEEE Eng Med Biol Soc 2011, 2011:2464-2467.
110. Buschmann J., Welti M., Hemmi S., Neuenschwander P., Baltes C., Giovanoli P., et al. Three-dimensional co-cultures of osteoblasts and endothelial cells in DegraPol foam: histological and high-field magnetic resonance imaging analyses of pre-engineered capillary networks in bone grafts. Tissue Eng Part A 2011, 17:291-299.
111. Kaigler D., Krebsbach P.H., West E.R., Horger K., Huang Y.C., Mooney D.J. Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J 2005, 19:665-667.
112. Correia C., Grayson W.L., Park M., Hutton D., Zhou B., Guo X.E., et al. In vitro model of vascularized bone: synergizing vascular development and osteogenesis. PLoS One 2011, 6:e28352.
113. Mendes L.F., Pirraco R.P., Szymczyk W., Frias A.M., Santos T.C., Reis R.L., et al. Perivascular-like cells contribute to the stability of the vascular network of osteogenic tissue formed from cell sheet-based constructs. PLoS One 2012, 7:e41051.
114. Usami K., Mizuno H., Okada K., Narita Y., Aoki M., Kondo T., et al. Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation. JBiomed Mater Res A 2009, 90:730-741.
115. Geuze R.E., Wegman F., Oner F.C., Dhert W.J., Alblas J. Influence of endothelial progenitor cells and platelet gel on tissue-engineered bone ectopically in goats. Tissue Eng Part A 2009, 15:3669-3677.
116. Fedorovich N.E., Haverslag R.T., Dhert W.J., Alblas J. The role of endothelial progenitor cells in prevascularized bone tissue engineering: development of heterogeneous constructs. Tissue Eng Part A 2010, 16:2355-2367.
117. Tsigkou O., Pomerantseva I., Spencer J.A., Redondo P.A., Hart A.R., O'Doherty E., et al. Engineered vascularized bone grafts. Proc Natl Acad Sci U S A 2010, 107:3311-3316.
118. Kaigler D., Krebsbach P.H., Wang Z., West E.R., Horger K., Mooney D.J. Transplanted endothelial cells enhance orthotopic bone regeneration. JDent Res 2006, 85:633-637.
119. Koob S., Torio-Padron N., Stark G.B., Hannig C., Stankovic Z., Finkenzeller G. Bone formation and neovascularization mediated by mesenchymal stem cells and endothelial cells incritical-sized calvarial defects. Tissue Eng Part A 2011, 17:311-321.
120. Kim J.Y., Jin G.Z., Park I.S., Kim J.N., Chun S.Y., Park E.K., et al. Evaluation of solid free-form fabrication-based scaffolds seeded with osteoblasts and human umbilical vein endothelial cells for use in vivo osteogenesis. Tissue Eng Part A 2010, 16:2229-2236.
121. He J., Decaris M.L., Leach J.K. Bioceramic-mediated trophic factor secretion by mesenchymal stem cells enhances in vitro endothelial cell persistence and in vivo angiogenesis. Tissue Eng Part A 2012, 18:1520-1528.
122. Grellier M., Granja P.L., Fricain J.C., Bidarra S.J., Renard M., Bareille R., et al. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 2009, 30:3271-3278.
123. Seebach C., Henrich D., Kähling C., Wilhelm K., Tami A.E., Alini M., et al. Endothelial progenitor cells and mesenchymal stem cells seeded onto beta-TCP granules enhance early vascularization and bone healing in a critical-sized bone defect in rats. Tissue Eng Part A 2010, 16:1961-1970.
124. Wang L., Rao R.R., Stegemann J.P. Delivery of mesenchymal stem cells in chitosan/collagen microbeads for orthopedic tissue repair. Cells Tissues Organs 2013, 3:333-343.
125. Rao R.R., Peterson A.W., Stegemann J.P. Osteogenic differentiation of adipose-derived and marrow-derived mesenchymal stem cells in modular protein/ceramic microbeads. JBiomed Mater Res A 2013, 101A:1531-1538.
126. Caldwell D.J., Rao R.R., Stegemann J.P. Assembly of discrete collagen-chitosan microenvironments into multiphase tissue constructs. Adv Healthc Mater 2012, [Epub ahead of print].